Key points are not available for this paper at this time.
These data support the long-term safety and efficacy of mepolizumab in patients with SEA.
Khatri et al. (Mon,) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: